Patient#	Sample#	DUSP1:(DUSP1, protein),	DUSP10:(DUSP10, protein),	DUSP16:(DUSP16, protein),	DUSP8:(DUSP8, protein),	MAP2K3:(MAP2K3, protein),	MAP2K4:(MAP2K4, protein),	MAP2K6:(MAP2K6, protein),	MAP3K12:(MAP3K12, protein),	MAP3K3:(MAP3K3, protein),	MAP3K7IP1:(MAP3K7IP1, protein),	PAK family:(PAK family, protein),	RIPK1:(RIPK1, protein),	Src Family Kinases-active:(Src Family Kinases-active, protein),	TRAF6:(TRAF6, protein),	MAPK11:(MAP2K6, active),(MAPK11, protein),	RAC1-CDC42/GTP/PAK family:(PAK family, active),(RAC1-CDC42/GTP, active),(interleukin-1 receptor activity, active),(response to UV, active),	RIP/MEKK3:(MAP3K3, active),(RIPK1, active),(tumor necrosis factor receptor activity, active),	TRAF6/MEKK3:(LPS, active),(MAP3K3, active),(TRAF6, active),(interleukin-1 receptor activity, active),	MAPK14:(MAP2K3, active),(MAP2K4, active),(MAP2K6, active),(MAPK14, protein),(RIP/MEKK3, active),	PGK/cGMP/p38 alpha:(MAP3K7IP1, active),(MAPK14, active),(PGK/cGMP, active),	p38 alpha/TAB1:(MAP3K7IP1, active),(MAPK14, active),(PGK/cGMP, active),(response to stress, active),	apoptosis:(p38 alpha/TAB1, active),	p38alpha-beta	p38alpha-beta-active:(MAP3K12, active),(RAC1-CDC42/GTP/PAK family, active),(RAC1/OSM/MEKK3/MKK3, active),(TRAF6/MEKK3, active),(p38alpha-beta, active),(p38alpha-beta-active, protein),	p38alpha-beta/MKP1:(DUSP1, active),(p38alpha-beta-active, active),	p38alpha-beta/MKP5:(DUSP10, active),(p38alpha-beta-active, active),	p38alpha-beta/MKP7:(DUSP16, active),(p38alpha-beta-active, active),	positive regulation of innate immune response:(p38alpha-beta-active, active),	
